Bøger af Linda Elsegood

A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination.

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? "[LDN] raises hopes of reversing memory loss in old age."--the Guardian Over 30,000 copies sold! Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? The LDN Book explains: The drug's origins Its primary mechanism The latest research from practicing physicians and pharmacists Compiled by Linda Elsegood of The LDN Research Trust--the world's largest LDN charity organization with over 19,000 members worldwide--the book features ten chapters contributed by medical professionals on LDN's efficacy and two patient-friendly appendices. The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.

The LDN 20-Year Anniversary Book is finally here!Low Dose Naltrexone (LDN) Testimonials come together to help celebrate the 20-year anniversary of the LDN Research Trust.New Horizons is a book to celebrate the 20th Anniversary of the LDN Research Trust, which is a nonprofit charity. The book contains LDN testimonials from LDN prescribers, pharmacists, researchers, and Patients from around the world to share their testimonials.Authors: Linda Elsegood, Pamela W. Smith, M.D., MPH, MS, J.Stephen Dickson, BSC (hons) MRPharmS, Dr. Elizabeth Livengood, NMD, Sarah J.Zielsdorf, MD, MS, Yusuf M. (JP)Saleeby, MD, Deanna Windham, DO, Kent Holtorf, MD, Sebastian Denison, RPh, FAAR, Professor Angus G. Dalgleish, FRCP FRCPathFMedSci and Wai M. Liu, PhD, Wai M. Liu, PhD, Nasha Winters, ND, FABNO, Yoon Hang "John" Kim, MD.